Arvinas to Participate in Upcoming Investor Conferences
NEW HAVEN, Conn., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology
Globe Newswire7-02-2023, 04:32
Summary Notice of Pendency and Proposed Settlement of Shareholder Derivative Actions 4-05-2024, 03:39